Regulatory Filings • Dec 3, 2025
Regulatory Filings
Open in ViewerOpens in native device viewer



Serialization, aggregation, and quality control at the heart of a strategic collaboration supporting growth and competitiveness
Travagliato (Brescia) / Verdellino (Bergamo), December 3, 2025 – The partnership continues between Antares Vision Group, the Italian multinational leader in traceability and quality control—ensuring product safety and supply chain transparency through integrated data management—and Fine Foods & Pharmaceuticals N.T.M. SpA, an independent Italian CSDMO (Contract Services Development & Manufacturing Organization) specializing in the contract development and manufacturing of products for the nutraceutical, pharmaceutical, and cosmetics industries, with a customer-centric, serviceoriented approach.
The collaboration, which includes the ongoing implementation of solutions for both the pharmaceutical and nutraceutical divisions, aims to ensure compliance with international traceability regulations, strengthen quality and safety processes, optimize the management of production data, and increase operational efficiency—while guaranteeing the highest standards of quality and regulatory compliance. Regarding the cosmetics sector, Antares Vision Group plans to support Fine Foods, and specifically its Fine Cosmetics SpA division, in expanding this market not only through technologies already implemented in Pharma but also through authentication technologies.
"The partnership with the Fine Foods Group reflects our commitment to providing scalable and integrated technological solutions that ensure transparency across the entire supply chain, supporting companies in the challenges of digitalization and regulatory compliance. We are proud to continue placing our expertise at the service of a partner that shares our focus on quality, innovation, and sustainability," stated Fabio Forestelli, CEO of Antares Vision Group.
"Innovation is a core part of our DNA and our history. We are constantly seeking out innovative technologies, and those from Antares Vision—integrated with the know-how of our teams—allow us to strengthen quality, safety, and compliance of processes, ensuring our customers receive always cuttingedge solutions. The collaboration with Antares Vision represents not only a technological investment for the Fine Foods Group but also an additional step toward generating sustainable, long-term value for us and our customers," commented Pietro Oriani, CEO of Fine Foods & Pharmaceuticals N.T.M. S.p.A.
Fine Foods Group has chosen to rely on Antares Vision Group's technologies and expertise by opting for full-stack solutions, with line-level (L1–L2), plant-level (L3), and corporate-level (L4) systems supporting corporate growth and production process innovation. In particular, the supply of the entire technological ecosystem ensures that Fine Foods remains compliant across all processes with the regulations governing the pharmaceutical sector. The Antares Vision Group solutions have been integrated into production lines built by internationally recognized OEMs and include:


These solutions are part of DIAMIND, Antares Vision Group's modular and integrated ecosystem, which encompasses all the Group's innovations and technologies. DIAMIND enables the digital transformation journey with a comprehensive data-driven plant management platform and enhances the supply chain with serialization, aggregation, and end-to-end visibility.
Antares Vision Group is the Italian multinational company that ensures product safety and supply chain transparency thanks to innovative technologies for quality control (inspection systems and machines), end-to-end traceability (serialization and aggregation solutions) and integrated data management (powered by artificial intelligence and integrated with blockchain). This is possible through DIAMIND, the integrated, modular ecosystem of solutions that guides the path toward digital transformation of companies, products and supply chains. The Group operates in the Life Science (pharmaceuticals, biomedical devices and hospitals), Cosmetics and FMCG (Fast-Moving Consumer Goods) sectors, supporting companies in digitalizing processes to improve sustainability, efficiency, productivity and visibility. It is a world leader in drug traceability, supplying the world's leading manufacturers (more than 50% of the top 20 multinationals) and numerous government authorities. It is present in more than 60 countries, employs more than 1,200 people and has a network of more than 40 international partners. The Company has been listed on the Euronext STAR Milan segment (EXM, AV:IM) since 2021 and reported revenues of €208 million in 2024, up 2% from 2023. www.antaresvisiongroup.com
Fine Foods & Pharmaceuticals N.T.M. S.p.A., listed on Euronext STAR Milan of Borsa Italiana (ticker: FF), is an independent Italian CSDMO (Contract Services Development & Manufacturing Organization) specializing in the third-party development and manufacturing of products for the nutraceutical, pharmaceutical, and cosmetic industries with a customer-focused service approach. Founded in 1984, Fine Foods has proven to be a reliable and competent strategic partner for clients across its various sectors, supported by an organization that enables successful project execution and long-term, solid relationships. The continuous pursuit of operational excellence is a core part of its business model: from research and development to innovation, from process reliability to product quality, from attention to ESG issues to the sustainable management of the Group's entire supply chain. Fine Foods is a benefit corporation, supported by certifications and ratings based on international standards that guarantee its commitment to sustainability across all company functions. www.finefoods.it/en/home-eng


Alessandro Baj Badino Head of IR & Corporate Communication +39 030 72 83 500 [email protected]
Davide Antonioli Corporate Communication, ESG & IR Senior +39 030 72 83 500 [email protected]
Federica Menichino +39 3496976982 [email protected]
Tel +39 035 4821382
Investor Relations: [email protected]
Media Relations: [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.